NCT00070382 2020-08-03Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for CancerJonsson Comprehensive Cancer CenterPhase 3 Completed14 enrolled
NCT03776032 2018-12-20A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing ChemotherapyAmgenPhase 3 Completed320 enrolled
NCT00148421 2013-05-15Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.AmgenPhase 3 Completed
NCT00091858 2013-05-08Study of Darbepoetin Alfa for the Treatment of Anemia of CancerAmgenPhase 3 Completed1,000 enrolled
NCT00118638 2013-04-29A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle ChemotherapyAmgenPhase 3 Completed705 enrolled
NCT00661999 2011-05-17Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With CancerMayo ClinicPhase 3 Completed502 enrolled 30 charts
NCT00110955 2010-01-15Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle ChemotherapyAmgenPhase 3 Completed391 enrolled
NCT00115167 2009-05-11A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 StudyAmgenPhase 3 Completed371 enrolled
NCT00111137 2008-02-28Treatment for Patients With Non-Myeloid Malignancies Receiving ChemotherapyAmgenPhase 3 Completed718 enrolled
NCT00117624 2007-12-28A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid MalignancyAmgenPhase 3 Completed